Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa—Part II: Procedural and Wound Care Therapies

Procedural treatments are a cornerstone of hidradenitis suppurativa (HS) management. New interventional therapies are being studied as part of the upsurge in HS research and clinical trials. Additionally, draining wounds can impart a significant negative impact on patients’ quality of life, requirin...

Full description

Saved in:
Bibliographic Details
Published inDermatology and therapy Vol. 13; no. 8; pp. 1699 - 1720
Main Authors Fragoso, Natalie M., Masson, Rahul, Gillenwater, T. Justin, Shi, Vivian Y., Hsiao, Jennifer L.
Format Journal Article
LanguageEnglish
Published Cheshire Springer Healthcare 01.08.2023
Springer
Adis, Springer Healthcare
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Procedural treatments are a cornerstone of hidradenitis suppurativa (HS) management. New interventional therapies are being studied as part of the upsurge in HS research and clinical trials. Additionally, draining wounds can impart a significant negative impact on patients’ quality of life, requiring daily dressing changes. However, standardized guidelines on how to best manage HS wounds both day-to-day and post-procedure are lacking. In part II of this emerging therapies review, procedural treatments and wound care dressings and devices that are being investigated for HS management are discussed.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2193-8210
2190-9172
DOI:10.1007/s13555-023-00957-5